Navigation Links
Acromegaly in Medical News

Options Improving for Patients With Acromegaly and Gigantism

Scientific, technological and medical advances made in the past two decades are leading to more definitive diagnoses, earlier and more effective treatment options/// and better outcomes for patients suffering from a condition called acromegaly. In the article, Shlomo Melmed, M.D., senior vice ...

Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results

...by Endo in the future upon achievement of certain milestones related to NEBIDO(R) (in development for hypogonadism) and octreotide (in development for acromegaly and carcinoid syndrome), two of the Company's primary product candidates. The acquisition will be effected by means of a tender offer for all the outs...

Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals

...sm) and the octreotide implant (in development for acromegaly and carcinoid syndrome), two of Indevus' primary p...he FDA for marketing and sale for the treatment of acromegaly or carcinoid syndrome. The tender offer is ex...-transmitted pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for stutteri...

Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals

...ncer, NEBIDO(R) for hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for stuttering. About Endo Pharmaceuticals Endo Pharmaceuticals is a specialty pharmaceutical compan...

Look younger with HGH!!

... Mr Prakash said: "Taken in low doses, research shows that human growth hormone is as safe as vitamin C”. Long-term usage can also result in acromegaly — a condition that causes oily skin, a large tongue and protruding forehead. Dr Cooper said: “Sufferers sometimes have a huge chin, huge spade-l...
Acromegaly in Medical Technology

FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)

...ncer, NEBIDO(R) for hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for stuttering. Safe Harbor Statement This press release contains forward-looking statements w...

Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study

...ncer, NEBIDO(R) for hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for stuttering. PRO 2000 PRO 2000 (a naphthalene sulfonate polymer) is under development as a topica...

Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering

...IDO(R) for male hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, and the octreotide implant for acromegaly and carcinoid syndrome. About Pagoclone Pagoclone is a novel, non-benzodiazepine, selective GABA-A receptor agonist. In clinical studies in anxiet...

ATL/TV1102 Trial Results Presented at World Congress on Treatment and Research in Multiple Sclerosis

...L1103 is a second-generation antisense drug designed to lower blood IGF-I levels and is entering pre-clinical development as a potential treatment for acromegaly and vision disorders. ATL/TV1102 (inhaled) is at the pre-clinical research stage as a potential treatment for asthma. ATL1101 is a second-generation a...

Indevus Pharmaceuticals Reports Positive Results of Phase II Octreotide Implant Trial

...same patented Hydron technology utilized in the Company's currently approved and marketed products SUPPRELIN(R) LA and VANTAS(R). About Acromegaly acromegaly is a chronic hormonal disorder that occurs when a pituitary tumor produces excess growth hormone, or GH. It most commonly affect middle- aged adults, ...

Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting

...ious partnering and product development strategies to move forward with PCK3145. - The pivotal Phase III clinical trial in Europe with Octreotide in acromegaly patients was initiated in February and Ambrilia obtained an IND with its U.S. licensing partner, Mallinckrodt, to conduct a pivotal Phase III clinical...
Acromegaly in Medical Products

Free IGF-I IRMA Test

Description:...mediating many of the actions of GH [6]. In GH deficiency, malnutrition [4] and GH-receptor deficiency [7], serum IGF-I levels are low. Conversely, in acromegaly (GH excess) serum IGF-I levels are elevated [4,6]. Measurement of IGF-I levels in serum is a useful diagnostic test for the clinical evaluation of GH-...
Company:Diagnostic Systems Laboratories, Inc.

IGF-I IRMA Test (With Extraction)

Description:...mediating many of the actions of GH [6]. In GH deficiency, malnutrition [4] and GH-receptor deficiency [7], serum IGF-I levels are low. Conversely, in acromegaly (GH excess) serum IGF-I levels are elevated [4,6]. Measurement of IGF-I levels in serum is a useful diagnostic test for the clinical evaluation of GH-...
Company:Diagnostic Systems Laboratories, Inc.

IGF-I ELISA Test (With Extraction)

Description:...mediating many of the actions of GH [6]. In GH deficiency, malnutrition [4] and GH-receptor deficiency [7], serum IGF-I levels are low. Conversely, in acromegaly (GH excess) serum IGF-I levels are elevated [4,6]. Measurement of IGF-I levels in serum is a useful diagnostic test for the clinical evaluation of GH-...
Company:Diagnostic Systems Laboratories, Inc.

IGF-I IRMA Test (Non-Extraction)

Description:...mediating many of the actions of GH [6]. In GH deficiency, malnutrition [4] and GH-receptor deficiency [7], serum IGF-I levels are low. Conversely, in acromegaly (GH excess) serum IGF-I levels are elevated [4,6]. Measurement of IGF-I levels in serum is a useful diagnostic test for the clinical evaluation of GH-...
Company:Diagnostic Systems Laboratories, Inc.

IGF-I ELISA Test (Non-Extraction)

Description:...mediating many of the actions of GH [6]. In GH deficiency, malnutrition [4] and GH-receptor deficiency [7], serum IGF-I levels are low. Conversely, in acromegaly (GH excess) serum IGF-I levels are elevated [4,6]. Measurement of IGF-I levels in serum is a useful diagnostic test for the clinical evaluation of GH-...
Company:Diagnostic Systems Laboratories, Inc.

Free IGF-I ELISA Test

Description:...mediating many of the actions of GH [6]. In GH deficiency, malnutrition [4] and GH-receptor deficiency [7], serum IGF-I levels are low. Conversely, in acromegaly (GH excess) serum IGF-I levels are elevated [4,6]. Measurement of IGF-I levels in serum is a useful diagnostic test for the clinical evaluation of GH-...
Company:Diagnostic Systems Laboratories, Inc.
Acromegaly in Medical Definition

Pathology

... Hypoparathyroidism ( Pseudohypoparathyroidism ) - Hyperparathyroidism ( Primary , Secondary , Tertiary ) Pituitary hyperfunction ( acromegaly , Hyperprolactinaemia , Syndrome of inappropriate antidiuretic hormone ) - Hypopituitarism ( Sheehan's syndrome , Kallmann syndrome , Simmonds' ...
Acromegaly in Medical Dictionary

Acromegaly

Acromegaly is a syndrome that results when the pituitary gland produces excess growth hormone (hGH) after epiphyseal plate closure at puberty. A number of disorders may increase the pituitary's GH output, although most... Defines acromegaly , a disorder caused by excess production ...

Giantism

...iantism at Dictionary.com a free online dictionary ... Link To giantism . acromegaly Facts. Get the facts and take charge of your condition. ... Definition ...often used to specifically denote growth hormone excess, the term ... acromegaly is a growth disorder caused by excessive production of growth hormone ......

Gigantism

...m is usually the result of hereditary and ... acromegaly and Gigantism Definition acromegaly is a disease in which an abnormality in the pitu...ess of growth hormone during ... A review of acromegaly & Gigantism with focus on etiology, pathogen...

Breech birth

... ... This means it is not the breech birth that causes the problem, but may be a ... Abandonment, Abdominal Wall Defects, Acetaminophen, Acne, acromegaly and Gigantism, Acting Out, Adaptive Behavior ... Breech birth is the delivery of a ... Delivery of a breech through the birth canal can be...

Brachial plexopathy

... in the arm and ... Brachial plexopathy Health Article. Save Email Print. Images ... Abandonment, Abdominal Wall Defects, Acetaminophen, Acne, acromegaly and Gigantism, Acting Out, Adaptive Behavior Scales ... Brachial plexopathy occurs most ... Brachial plexopathy - Overview, Brachial pl...

Agammaglobulinemia

...s/Candler, Savannah Georgia ... Agammaglobulinemia is rare disorder that primarily ... Abandonment, Abdominal Wall Defects, Acetaminophen, Acne, acromegaly and Gigantism, Acting Out, Adaptive Behavior Scales for Infants and Early Childhood, Addiction, ... ...
Acromegaly in Biological Technology

Indevus Pharmaceuticals Announces Release of 2008 Annual Report

...ncer, NEBIDO(R) for hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for stuttering. Contact: Michael W. Rogers EVP and Chief Financial Officer (781) 861-8444...

Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results

...Trial of PRO 2000 -- Phase III Clinical Trial of Octreotide Implant for acromegaly Initiated Business Development -- Licensing of European Rights fo...by HIV and other sexually-transmitted pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for stuttering. About SANCTUR...

Indevus Pharmaceuticals to Present at Upcoming Investor Conferences

... NEBIDO(R) for male hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for stuttering. Forward Looking Statements Except for the descriptions of historical facts contained herein,...

Indevus and FDA Agree on Path Forward for NEBIDO(R)

...IDO(R) for male hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, and the octreotide implant for acromegaly and carcinoid syndrome. Forward Looking Statements Except for the descriptions of historical facts contained herein, this press release contains f...

Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery

...me-positive chronic myelogenous leukemia (Ph+ CML) and five other rare diseases. Novartis also has a therapy for the treatment of carcinoid tumors and acromegaly and multiple treatments in the pipeline targeting rare diseases. Filing data The study on which the regulatory filing is based compared the recurr...

Indevus Announces Private Placement of $105 Million of Non-Recourse Notes

...IDO(R) for male hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, and the octreotide implant for acromegaly and carcinoid syndrome. Forward Looking Statements Except for the descriptions of historical facts contained herein, this press release contains f...
Acromegaly in Biological Dictionary

Pituitary gland

...tion, the pituitary gland produces growth hormone for normal development ... PNA Disorders Section - Introduction to the Pituitary Gland . acromegaly ... Structurally, the pituitary gland is divided into a larger anterior region ... pituitary gland n. A small oval endocrine gland attach...
Other Tags
(Date:10/22/2014)... Lexington, Kentucky (PRWEB) October 22, 2014 ... an agreement that will change the current location of ... Road to South Limestone across from the University of ... be a state-of-the-art ambulatory care center, owned and operated ... meet the orthopaedic needs of children and their families ...
(Date:10/22/2014)... With the Affordable Care Act (ACA) open enrollment ... Institutes for Research (AIR) finds that three out of four ... but 42 percent say they are not likely or only ... for coverage. , The AIR survey found wide gaps in ... calculate correctly how much they owe for a routine doctor’s ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Healthcare ... completing their continuing education at home or on-the-go ... access to 20 brand new, premium Seminar-on-Demand CE ... catalog of over 2,000 hours of ... customize their educational experience. With such a diverse ...
(Date:10/22/2014)... Mission Viejo, CA (PRWEB) October 22, 2014 ... that Jay Cormier, Sr. Vice President of Sales, will ... at the upcoming Meetings Technology Expo on October 28, ... will also be hosting a booth as well as ... on how Lintelus Meeting can create a more engaging ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, ... length may be showing a genetic propensity for obesity as ... have been linked to increased body fat, but the same ... muscle, the researchers said. At 1 year, kids with ... and 3, however, these genes were linked to excessive weight ...
Breaking Medicine News(10 mins):Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2
(Date:10/16/2014)... -- NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market announces that ... Smart Wallet, at the 13 th annual Future ... conference on the intersection of technology and the economy. ... founder and publisher of the Strategic News Service™, the ...
(Date:10/15/2014)... our ability to assess the pandemic risk from strains ... we must not allow ourselves to become complacent that ... international consortium of scientists. , Influenza pandemics arise when ... yet to develop widespread immunity – spreads in the ... the past 100 years, the worst of which – ...
(Date:10/15/2014)... Gauß-Allianz has admitted Johannes Gutenberg University Mainz (JGU) ... science hub continues to maintain a significant nationwide ... , "The acceptance of Johannes Gutenberg University Mainz ... a milestone in the national and international competition ... state of Rhineland-Palatinate can be proud that Mainz ...
Breaking Biology News(10 mins):NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3
Other Contents